Skip to main content

Namzaric® for Irradiated Primary Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled 24-Week Clinical Trial

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Allergan, Inc.

Start Date

July 19, 2021

End Date

December 15, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Allergan, Inc.

Start Date

July 19, 2021

End Date

December 15, 2023